EVALUATION OF HIGH-DOSE ARA-C (HDA) IN TREATMENT OF CHILDHOOD T-CELL ACUTE LYMPHOBLASTIC-LEUKEMIA (T-ALL) AND ADVANCED-STAGE LYMPHOBLASTIC NON-GROUP (POG) STUDY

被引：0
|
作者：
KATZ, JA
AMYLON, MA
RAVINDRANATH, Y
SHUSTER, JJ
机构：
[1] UNIV TEXAS,SW MED CTR,DALLAS,TX 75230
[2] STANFORD UNIV,PALO ALTO,CA 94304
[3] WAYNE STATE UNIV,DETROIT,MI 48202
[4] UNIV FLORIDA,POG STAT OFF,GAINESVILLE,FL 32611
来源：
BLOOD | 1994年 / 84卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A145 / A145
页数：1
相关论文
共 50 条
  • [21] High survival rate with the LMT-89 regimen in lymphoblastic lymphoma (LL), but not in T-cell acute lymphoblastic leukemia (T-ALL)
    Jabbour, E
    Koscielny, S
    Sebban, C
    Peslin, N
    Patte, C
    Gargi, T
    Biron, P
    Fermé, C
    Bourhis, JH
    Vantelon, JM
    Arnaud, P
    Ribrag, V
    LEUKEMIA, 2006, 20 (05) : 814 - 819
  • [22] Transcriptional Regulation of Oncogenic MEF2C In T-Cell Acute Lymphoblastic Leukemia (T-ALL)
    Nagel, Stefan
    Venturini, Letizia
    Meyer, Corinna
    Kaufmann, Maren
    Scherr, Michaela
    Drexler, Hans G.
    MacLeod, Roderick A. F.
    BLOOD, 2010, 116 (21) : 1496 - 1496
  • [23] A single high dose of idarubicin combined with high dose ARA-C for the treatment of first recurrent childhood "high-risk" acute lymphoblastic leukemia (ALL).
    Testi, AM
    Del Giudice, I
    Arcese, W
    Moleti, ML
    Giona, F
    Arico, M
    Basso, G
    Conter, V
    Messina, C
    Rondelli, R
    Uderzo, C
    Micalizzi, MC
    Barisone, E
    Locatelli, F
    Dini, G
    Casale, F
    Valsecchi, MG
    Masera, G
    Mandelli, F
    BLOOD, 2000, 96 (11) : 719A - 719A
  • [24] INFLUENCE OF INTENSIVE ASPARAGINASE IN THE TREATMENT OF CHILDHOOD NON-T-CELL ACUTE LYMPHOBLASTIC-LEUKEMIA
    SALLAN, SE
    HITCHCOCKBRYAN, S
    GELBER, R
    CASSADY, JR
    FREI, E
    NATHAN, DG
    CANCER RESEARCH, 1983, 43 (11) : 5601 - 5607
  • [25] Results of Treatment with Nelarabine in Relapsed T-Cell Acute Lymphoblastic Leukemia (T-ALL) in Children - Report of Polish Paediatric Leukemia/Lymphoma Study Group (PPLLSG)
    Marciniak-Stepak, P.
    Derwich, K.
    Owoc-Lempach, J.
    Mielcarek-Siedziuk, M.
    Balwierz, W.
    Krawczuk-Rybak, M.
    Szczepanski, T.
    Wachowiak, J.
    Gorczynska, E.
    PEDIATRIC BLOOD & CANCER, 2017, 64 : S171 - S172
  • [26] Antimetabolite-based therapy in childhood T-cell acute lymphoblastic leukemia: A report of POG study 9296
    Winter, SS
    Holdsworth, MT
    Devidas, M
    Raisch, DW
    Chauvenet, A
    Ravindranath, Y
    Ducore, JM
    Amylon, MD
    PEDIATRIC BLOOD & CANCER, 2006, 46 (02) : 179 - 186
  • [27] CLASSIFICATION OF ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) OF CHILDHOOD AND INFANCY BY IMMUNOGLOBULIN AND T-CELL RECEPTOR GENE PATTERNS
    FELIX, CA
    KIRSCH, IR
    REAMAN, GH
    KORSMEYER, SJ
    COLE, DE
    POPLACK, DG
    MEDICAL AND PEDIATRIC ONCOLOGY, 1988, 16 (06): : 402 - 402
  • [28] SPECIFIC EXPRESSION OF DISIALOLACTOSYLCERAMIDE (GD3) IN T-CELL ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) OF CHILDHOOD
    REAMAN, GH
    TAYLOR, BJ
    MERRITT, WD
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1987, 28 : 183 - 183
  • [29] Intensive high-dose asparaginase consolidation improves survival for pediatric patients with T cell acute lymphoblastic leukemia and advanced stage lymphoblastic lymphoma: a Pediatric Oncology Group study
    Amylon, MD
    Shuster, J
    Pullen, J
    Berard, C
    Link, MP
    Wharam, M
    Katz, J
    Yu, A
    Laver, J
    Ravindranath, Y
    Kurtzberg, J
    Desai, S
    Camitta, B
    Murphy, SB
    LEUKEMIA, 1999, 13 (03) : 335 - 342
  • [30] Intensive high-dose asparaginase consolidation improves survival for pediatric patients with T cell acute lymphoblastic leukemia and advanced stage lymphoblastic lymphoma: a Pediatric Oncology Group study
    MD Amylon
    J Shuster
    J Pullen
    C Berard
    MP Link
    M Wharam
    J Katz
    A Yu
    J Laver
    Y Ravindranath
    J Kurtzberg
    S Desai
    B Camitta
    SB Murphy
    Leukemia, 1999, 13 : 335 - 342
12345